| Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population F Efficace, M Baccarani, M Breccia, G Alimena, G Rosti, F Cottone, ... Blood, The Journal of the American Society of Hematology 118 (17), 4554-4560, 2011 | 304 | 2011 |
| Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib F Efficace, M Baccarani, M Breccia, F Cottone, G Alimena, GL Deliliers, ... Leukemia 27 (7), 1511-1519, 2013 | 156 | 2013 |
| Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study F Efficace, M Baccarani, G Rosti, F Cottone, F Castagnetti, M Breccia, ... British journal of cancer 107 (6), 904-909, 2012 | 129 | 2012 |
| Patient-versus physician-reporting of symptoms and health status in chronic myeloid leukemia F Efficace, G Rosti, N Aaronson, F Cottone, E Angelucci, S Molica, ... Haematologica 99 (4), 788, 2014 | 111 | 2014 |
| Distribution-and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review A Ousmen, C Touraine, N Deliu, F Cottone, F Bonnetain, F Efficace, ... Health and quality of life outcomes 16, 1-12, 2018 | 93 | 2018 |
| Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of … F Efficace, F Mandelli, G Avvisati, F Cottone, F Ferrara, E Di Bona, ... J Clin Oncol 32 (30), 3406-3412, 2014 | 93 | 2014 |
| Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study F Efficace, G Gaidano, M Breccia, MT Voso, F Cottone, E Angelucci, ... The Lancet Oncology 16 (15), 1506-1514, 2015 | 86 | 2015 |
| Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis MV Fabio Efficace, Gary S. Collins, Francesco Cottone, Johannes M. Giesinger ... Value in Health, 2021 | 80 | 2021 |
| Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes F Efficace, G Gaidano, M Breccia, M Criscuolo, F Cottone, G Caocci, ... British journal of haematology 168 (3), 361-370, 2015 | 77 | 2015 |
| Leaving home, family support and intergenerational ties in Italy: Some regional differences E Santarelli, F Cottone Demographic Research 21, 1-22, 2009 | 77 | 2009 |
| Health‐related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease F Efficace, F Mandelli, P Fazi, C Santoro, G Gaidano, F Cottone, ... American journal of hematology 91 (10), 995-1001, 2016 | 66 | 2016 |
| Past and current practice of patient-reported outcome measurement in randomized cancer clinical trials: a systematic review JM Giesinger, F Efficace, N Aaronson, M Calvert, D Kyte, F Cottone, ... Value in Health 24 (4), 585-591, 2021 | 56 | 2021 |
| Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitors F Efficace, G Rosti, F Cottone, M Breccia, F Castagnetti, A Iurlo, F Mandelli, ... Leukemia research 38 (3), 294-298, 2014 | 53 | 2014 |
| Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review F Efficace, A Cardoni, F Cottone, M Vignetti, F Mandelli Leukemia Research 37 (2), 206-213, 2013 | 50 | 2013 |
| Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes F Efficace, G Gaidano, M Sprangers, F Cottone, M Breccia, MT Voso, ... Annals of oncology 25 (2), 447-454, 2014 | 46 | 2014 |
| Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy F Efficace, F Stagno, A Iurlo, M Breccia, F Cottone, M Bonifacio, ... Leukemia 34 (2), 488-498, 2020 | 39 | 2020 |
| Patient‐reported outcomes enhance the survival prediction of traditional disease risk classifications: an international study in patients with myelodysplastic syndromes F Efficace, F Cottone, G Abel, P Niscola, G Gaidano, F Bonnetain, A Anota, ... Cancer 124 (6), 1251-1259, 2018 | 38 | 2018 |
| Wideband electrostatic vibration energy harvester (e-veh) having a low start-up voltage employing a high-voltage integrated interface A Dudka, P Basset, F Cottone, E Blokhina, D Galayko Journal of Physics: Conference Series 476 (1), 012127, 2013 | 31 | 2013 |
| Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 summary score in patients with hematologic malignancies F Efficace, F Cottone, K Sommer, J Kieffer, N Aaronson, P Fayers, ... Value in Health 22 (11), 1303-1310, 2019 | 29 | 2019 |
| Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review R Chakraborty, L Cannella, F Cottone, F Efficace The Lancet Haematology 7 (12), e892-e901, 2020 | 27 | 2020 |
massimo brecciaSapienza UniversityEmail verificata su bce.uniroma1.it
